Defective proviruses rapidly accumulate during acute HIV-1 infection

Cited by (745)

Items 101–200 of 745

1. The role of integration and clonal expansion in HIV infection: live long and prosper
   Elizabeth M. Anderson, Frank M. Maldarelli · 2018 · Retrovirology
2. Longitudinal Dynamics of Intact HIV Proviral DNA and Outgrowth Virus Frequencies in a Cohort of Individuals Receiving Antiretroviral Therapy
   Shane D. Falcinelli, Kayla W. Kilpatrick, Jenna Read, Ross Murtagh, Brigitte Allard, Simon Ghofrani, Jennifer Kirchherr, Katherine Sholtis James, Erin L. Stuelke, Caroline Baker et al. · 2020 · The Journal of Infectious Diseases
3. Novel assay reveals a large, inducible, replication-competent HIV-1 reservoir in resting CD4+ T cells
   Anwesha Sanyal, Robbie B. Mailliard, Charles R. Rinaldo, Deena M. Ratner, Ming Ding, Yue Chen, Jennifer M. Zerbato, Nicholas S. Giacobbi, Narasimhan J. Venkatachari, Bruce Kendrick Patterson et al. · 2017 · Nature Medicine
4. Block and Lock HIV Cure Strategies to Control the Latent Reservoir
   Chantelle Ahlenstiel, Geoff P. Symonds, Stephen John Kent, Anthony Dominic Kelleher · 2020 · Frontiers in Cellular and Infection Microbiology
5. Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir
   Zheng Wang, Francesco Roberto Simonetti, Robert F. Siliciano, Gregory M. Laird · 2018 · Retrovirology
6. Sequence Evaluation and Comparative Analysis of Novel Assays for Intact Proviral HIV-1 DNA
   Christian Gaebler, Shane D. Falcinelli, Elina Stoffel, Jenna Read, Ross Murtagh, Thiago Y. Oliveira, Víctor Ramos, Julio C. C. Lorenzi, Jennifer Kirchherr, Katherine Sholtis James et al. · 2020 · Journal of Virology
7. Infectious Virus Persists in CD4 + T Cells and Macrophages in Antiretroviral Therapy-Suppressed Simian Immunodeficiency Virus-Infected Macaques
   Celina Monteiro Abreu, Rebecca T. Veenhuis, Claudia R. Avalos, Shelby Graham, Suzanne E. Queen, Erin N. Shirk, Brandon T. Bullock, Ming Li, Kelly A. Metcalf Pate, Sarah E. Beck et al. · 2019 · Journal of Virology
8. Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain
   Eugene L. Asahchop, Oussama Méziane, Manmeet K. Mamik, Wing Fuk Chan, William G. Branton, Lothar Resch, Michael John Gill, Élie Haddad, Jean Victor Guimond, Mark A. Wainberg et al. · 2017 · Retrovirology
9. Between a shock and a hard place: challenges and developments in HIV latency reversal
   Jennifer M. Zerbato, Harrison V Purves, Sharon R. Lewin, Thomas A. Rasmussen · 2019 · Current Opinion in Virology
10. Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption
    Line K. Vibholm, Julio C. C. Lorenzi, Joy A. Pai, Yehuda Z. Cohen, Thiago Y. Oliveira, John P. Barton, Marco Garcia Noceda, Ching-Lan Lu, Yuria Ablanedo‐Terrazas, Perla M. Del Río Estrada et al. · 2019 · Journal of Virology
11. New Frontiers in Measuring and Characterizing the HIV Reservoir
    Shane D. Falcinelli, Cristina Ceriani, David M. Margolis, Nancie M. Archin · 2019 · Frontiers in Microbiology
12. Future technologies for monitoring HIV drug resistance and cure
    Urvi M. Parikh, Kevin D. McCormick, Gert Uves van Zyl · 2017 · Current Opinion in HIV and AIDS
13. Multiparametric characterization of rare HIV-infected cells using an RNA-flow FISH technique
    Amy E. Baxter, Julia Niessl, Rémi Fromentin, Jonathan Richard, Filippos Porichis, Marta Massanella, Nathalie Brassard, Nirmin Alsahafi, Jean‐Pierre Routy, Andrés Finzi et al. · 2017 · Nature Protocols
14. The multifaceted nature of HIV latency
    Caroline Dufour, Pierre Gantner, Rémi Fromentin, Nicolas Chomont · 2021 · Journal of Clinical Investigation
15. Distinct intestinal microbial signatures linked to accelerated systemic and intestinal biological aging
    Shalini Thakur Singh, Leila B. Giron, Maliha W. Shaikh, Shivanjali Shankaran, Phillip A. Engen, Zlata R. Bogin, Simona A. Bambi, Aaron R. Goldman, Joao L. L. C. Azevedo, Lorena Orgaz et al. · 2024 · Microbiome
16. Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study
    Nathan W. Cummins, Stacey A. Rizza, Mark Robert Litzow et al. · 2017 · PLoS Medicine
17. Heterogeneity in HIV and cellular transcription profiles in cell line models of latent and productive infection: implications for HIV latency
    Sushama Telwatte, Sara Morón‐López, Dvir Aran, Peggy Kim, Christine L. Hsieh, Sunil Kumar Joshi, Mauricio Montaño, Warner C. Greene, Atul Janardhan Butte, Joseph K. Wong et al. · 2019 · Retrovirology
18. Sex Differences in Human Immunodeficiency Virus Persistence and Reservoir Size During Aging
    Sara Gianella, Stephen A. Rawlings, Curtis N. Dobrowolski, Masato Nakazawa, Antoine Chaillon, Matthew C. Strain, Laura Layman, Gemma Caballero, Eileen P. Scully, Brianna Scott et al. · 2021 · Clinical Infectious Diseases
19. Insights Into Persistent HIV-1 Infection and Functional Cure: Novel Capabilities and Strategies
    Tram M. Ta, Sajjaf Malik, Elizabeth M. Anderson, Amber D. Jones, Jocelyn Perchik, Maryann Freylikh, Luca Sardo, Zackary A. Klase, Taisuke Izumi · 2022 · Frontiers in Microbiology
20. Phylogenetic approach to recover integration dates of latent HIV sequences within-host
    Bradley R. Jones, Natalie N. Kinloch, J. Horacsek, Bruce Ganase, Marianne Harris, P. Richard Harrigan, Richard Brad Jones, Mark A. Brockman, Jeffrey B. Joy, Art F. Y. Poon et al. · 2018 · Proceedings of the National Academy of Sciences
21. Combined single-cell transcriptional, translational, and genomic profiling reveals HIV-1 reservoir diversity
    Gérémy Sannier, Mathieu Dubé, Caroline Dufour, Corentin Richard, Nathalie Brassard, Gloria-Gabrielle Ortega-Delgado, Amélie Pagliuzza, Amy E. Baxter, Julia Niessl, Elsa Brunet‐Ratnasingham et al. · 2021 · Cell Reports
22. Near full-length HIV sequencing in multiple tissues collected postmortem reveals shared clonal expansions across distinct reservoirs during ART
    Caroline Dufour, María Julia Ruiz, Amélie Pagliuzza, Corentin Richard, Aniqa Shahid, Rémi Fromentin, Rosalie Ponte, Amélie Cattin, Tomas Raul Wiche Salinas, Syim Salahuddin et al. · 2023 · Cell Reports
23. Dynamics of HIV DNA reservoir seeding in a cohort of superinfected Kenyan women
    Mark D Pankau, Daniel B. Reeves, Elias Harkins, Keshet Ronen, Walter Godfrey Jaoko, Kishor N. Mandaliya, Susan Marie Graham, R. Scott McClelland, Frederick A. Matsen IV, Joshua Tisdell Schiffer et al. · 2020 · PLoS Pathogens
24. HIV-1 variants are archived throughout infection and persist in the reservoir
    Kelsie Brooks, Bradley R. Jones, Dario Alberto Dilernia, Daniel J. Wilkins, Daniel T. Claiborne, Samantha McInally, Jill W Gilmour, William Kilembe, Jeffrey B. Joy, Susan A Allen et al. · 2020 · PLoS Pathogens
25. Persistence of an intact HIV reservoir in phenotypically naive T cells
    Emmanuele Venanzi Rullo, Marilia Rita Pinzone, LaMont Cannon · 2020 · JCI Insight
26. HIV replication and latency in monocytes and macrophages
    Rebecca T. Veenhuis, Celina Monteiro Abreu, Erin N. Shirk, Lúcio Gama, Janice E. Clements · 2021 · Seminars in Immunology
27. Immune Control of HIV
    Muthukumar Balasubramaniam, Jui Pandhare, Chandravanu Dash · 2019 · JoLS Journal of Life Sciences
28. Engineering CAR T Cells to Target the HIV Reservoir
    Wenli Mu, Mayra A. Carrillo, Scott G. Kitchen · 2020 · Frontiers in Cellular and Infection Microbiology
29. T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy
    Allison S. Thomas, Kimberley L. Jones, Rajesh Tim Gandhi, Deborah K. McMahon, Joshua C. Cyktor, Dora Chan, Szu-Han Huang, Ronald Truong, Alberto Bosque, Amanda B. Macedo et al. · 2017 · PLoS Pathogens
30. Integration in oncogenes plays only a minor role in determining the in vivo distribution of HIV integration sites before or during suppressive antiretroviral therapy
    John M. Coffin, Michael J. Bale, Daria Wells, Shuang Guo, Brian T. Luke, Jennifer M. Zerbato, Michele D. Sobolewski, Twan W. Sia, Wei Shao, Xiaolin Wu et al. · 2021 · PLoS Pathogens
31. The model student: GPT-4 performance on graduate biomedical science exams
    Daniel Stribling, Yu-jie Xia, M. Amer, Kiley S. Graim, Connie J. Mulligan, Rolf Renne · 2024 · Scientific Reports
32. Multiplex single-cell visualization of nucleic acids and protein during HIV infection
    Maritza Puray‐Chavez, Philip R. Tedbury, Andrew D. Huber, Obiaara B. Ukah, Vincent Yapo, Dandan Liu, Juan Ji, Jennifer J. Wolf, Alan Engelman, Stefan G. Sarafianos · 2017 · Nature Communications
33. Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunity
    Mariya B. Shapiro, Tracy Cheever, Delphine C. Malherbe, Shilpi Pandey, Jason S. Reed, Eun Sung Yang, Keyun Wang, Amarendra Pegu, Xuejun Chen, Don C. Siess et al. · 2020 · Nature Communications
34. Key Players in HIV-1 Transcriptional Regulation: Targets for a Functional Cure
    Luisa Mori, Susana T. Valente · 2020 · Viruses
35. The Role of APOBECs in Viral Replication
    Wendy Kaichun Xu, Hyewon Byun, Jaquelin P. Dudley · 2020 · Microorganisms
36. Persistent expansion and Th1-like skewing of HIV-specific circulating T follicular helper cells during antiretroviral therapy
    Julia Niessl, Amy E. Baxter, Antigoni Morou, Elsa Brunet‐Ratnasingham, Gérémy Sannier, Gabrielle Gendron‐Lepage, Jonathan Richard, Gloria-Gabrielle Ortega-Delgado, Nathalie Brassard, Isabelle Turcotte et al. · 2020 · EBioMedicine
37. Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: Results from a randomised clinical trial
    Ricardo Sobhie Diaz, Iart Luca Shytaj, Leila B. Giron, Benedikt Obermaier, Ermelindo Della Líbera, Juliana Galinskas, Danilo Dias, James Hunter, Luiz Mário Janini, Gisele Cristina Gosuen et al. · 2019 · International Journal of Antimicrobial Agents
38. Measuring the latent reservoir for HIV-1: Quantification bias in near full-length genome sequencing methods
    Jennifer A. White, Joshua T. Kufera, Niklas Bachmann, Weiwei Dai, Francesco Roberto Simonetti, Ciara Armstrong, Jun Lai, Subul A. Beg, Janet D'Angelo Siliciano, Robert F. Siliciano · 2022 · PLoS Pathogens
39. Improved assays to measure and characterize the inducible HIV reservoir
    Marta Massanella, Christina Yek, Steven M. Lada, Masato Nakazawa, Neda Shefa, Karissa Huang, Douglas D. Richman · 2018 · EBioMedicine
40. Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells
    Carolyn Chu, Daniele Armenia, Charles Walworth, Maria Mercedes Santoro, Robert W. Shafer · 2022 · Clinical Microbiology Reviews
41. Recent progress in understanding HIV reservoirs
    Hsiao-Hsuan Kuo, Mathias D. Lichterfeld · 2017 · Current Opinion in HIV and AIDS
42. Follicular CD4 T Helper Cells As a Major HIV Reservoir Compartment: A Molecular Perspective
    Malika Aïd, Frank P. Dupuy, Eirini Moysi, Susan L. Moir, Elias K. Haddad, Jacob D. Estes, Rafick‐Pierre Sékaly, Constantinos Petrovas, Susan Pereira Ribeiro · 2018 · Frontiers in Immunology
43. HIV-1 Proviral Transcription and Latency in the New Era
    Ashutosh Shukla, Nora-Guadalupe P. Ramirez, Iván D’Orso · 2020 · Viruses
44. Phenotypic characterization of single CD4+ T cells harboring genetically intact and inducible HIV genomes
    Caroline Dufour, Corentin Richard, Marion Pardons, Marta Massanella, Antoine Ackaoui, Ben Murrell, Bertrand Routy, Réjean Thomas, Jean‐Pierre Routy, Rémi Fromentin et al. · 2023 · Nature Communications
45. A sample-in-digital-answer-out system for rapid detection and quantitation of infectious pathogens in bodily fluids
    Haowen Yang, Zhu Chen, Xiaobao Cao, Zhiyang Li, Stavros Stavrakis, Jaebum Choo, Andrew J. deMello, Philip D. Howes, Nongyue He · 2018 · Analytical and Bioanalytical Chemistry
46. Reduced HIV-1 latent reservoir outgrowth and distinct immune correlates among women in Rakai, Uganda
    Jessica L. Prodger, Adam A. Capoferri, Katherine M. Yu, Jun Lai, Steven James Reynolds, Jingo Kasule, Taddeo Kityamuweesi, Paul Buule, David Serwadda, Kyungyoon J. Kwon et al. · 2020 · JCI Insight
47. Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure
    Janet D'Angelo Siliciano, Robert F. Siliciano · 2020 · The Journal of Infectious Diseases
48. Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency
    Jennifer M. Zerbato, Georges Khoury, Wei Dong Zhao, Matthew J. Gartner, Rachel D. Pascoe, Ajantha Rhodes, Ashanti Dantanarayana, Megan Gooey, Jenny L. Anderson, Peter Bacchetti et al. · 2021 · EBioMedicine
49. Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells
    Nathan L. Board, Zhe Yuan, Fengting Wu, Milica Moskovljevic, Meghana Ravi, Srona Sengupta, Sung Soo Mun, Francesco Roberto Simonetti, Jun Lai, Pablo Tebas et al. · 2024 · Nature Immunology
50. HIV-1 DNA-capture-seq is a useful tool for the comprehensive characterization of HIV-1 provirus
    Saori C. Iwase, Paola Miyazato, Hiroo Katsuya, Saiful Islam, Benjy J.Y. Tan, Jumpei Ito, Misaki Matsuo, Hiroaki Takeuchi, Takaomi Ishida, Kouki Matsuda et al. · 2019 · Scientific Reports
51. Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms
    Jana L. Jacobs, Elias Konstantine Halvas, Melissa A. Tosiano, John W. Mellors · 2019 · Frontiers in Microbiology
52. Imaging HIV-1 Genomic DNA from Entry through Productive Infection
    Ryan D. Stultz, Jennifer J. Cenker, David J. McDonald · 2017 · Journal of Virology
53. An analytical pipeline for identifying and mapping the integration sites of HIV and other retroviruses
    Daria Wells, Shuang Guo, Wei Shao, Michael J. Bale, John M. Coffin, Stephen H. Hughes, Xiaolin Wu · 2020 · BMC Genomics
54. Measuring the Success of HIV-1 Cure Strategies
    Jordan Thomas, Alessandra Ruggiero, William A. Paxton, Georgios P. Pollakis · 2020 · Frontiers in Cellular and Infection Microbiology
55. Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells
    John K. Bui, Elias Konstantine Halvas, Elizabeth Fyne, Michele D. Sobolewski, Dianna L. Koontz, Wei Shao, Brian T. Luke, Feiyu F. Hong, Mary F. Kearney, John W. Mellors · 2017 · PLoS Pathogens
56. Biochemical Basis of APOBEC3 Deoxycytidine Deaminase Activity on Diverse DNA Substrates
    Madison B. Adolph, Robin P. Love, Linda Chelico · 2018 · ACS Infectious Diseases
57. HIV Reservoirs and Treatment Strategies toward Curing HIV Infection
    Matsuda, Kouki, Maeda, Kenji · 2024 · International Journal of Molecular Sciences
58. HIV-1 Reservoir Persistence and Decay: Implications for Cure Strategies
    Edward F. Kreider, Katharine J. Bar · 2022 · Current HIV/AIDS Reports
59. Hematopoietic Stem and Progenitor Cells Are a Distinct HIV Reservoir that Contributes to Persistent Viremia in Suppressed Patients
    Thomas D. Zaikos, Valeri H. Terry, Nadia T. Sebastian, Jay Lubow, Mark M. Painter, Maria Virgilio, Andrew J. Neevel, Frances Taschuk, Adewunmi Onafuwa-Nuga, Lucy A. McNamara et al. · 2018 · Cell Reports
60. Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals
    Elizabeth R. Wonderlich, Krupa Subramanian, Bryan D. Cox, Ann P. Wiegand, Carol Lackman-Smith, Michael J. Bale, Mars Stone, Rebecca Hoh, Mary F. Kearney, Frank M. Maldarelli et al. · 2019 · PLoS Pathogens
61. CD32+CD4+ T Cells Are Highly Enriched for HIV DNA and Can Support Transcriptional Latency
    Gilles Darcis, Neeltje A. Kootstra, Berend Hooibrink, Thijs van Montfort, Irma Maurer, Kevin Groen, Suzanne Jurriaans, Margreet E. Bakker, Carine M. Van Lint, Ben Berkhout et al. · 2020 · Cell Reports
62. HIV reservoir quantification using cross-subtype multiplex ddPCR
    Noah A.J. Cassidy, Carolyn S. Fish, Claire Levy, Pavitra Roychoudhury, Daniel B. Reeves, Sean M. Hughes, Joshua Tisdell Schiffer, Sarah F. Benki-Nugent, Grace C. John-Stewart, Dalton C. Wamalwa et al. · 2021 · iScience
63. Why the HIV Reservoir Never Runs Dry: Clonal Expansion and the Characteristics of HIV-Infected Cells Challenge Strategies to Cure and Control HIV Infection
    Chuen‐Yen Lau, Matthew A. Adan, Frank M. Maldarelli · 2021 · Viruses
64. Droplet-microfluidics-assisted sequencing of HIV proviruses and their integration sites in cells from people on antiretroviral therapy
    Chen Sun, Leqian Liu, Liliana Pérez, Xiangpeng Li, Yifan Liu, Peng Xu, Eli Boritz, James I. Mullins, Adam R. Abate · 2022 · Nature Biomedical Engineering
65. Defective HIV-1 genomes and their potential impact on HIV pathogenesis
    Jeffrey Kuniholm, Carolyn Coote, Andrew J. Henderson · 2022 · Retrovirology
66. Distinct gene expression by expanded clones of quiescent memory CD4+ T cells harboring intact latent HIV-1 proviruses
    Georg H.J. Weymar, Yotam Bar‐On, Thiago Y. Oliveira, Christian Gaebler, Víctor Ramos, Harald Hartweger, Gaëlle Breton, Marina F. Caskey, Lillian B. Cohn, Mila Janković et al. · 2022 · Cell Reports
67. Impact of misclassified defective proviruses on HIV reservoir measurements
    Daniel B. Reeves, Christian Gaebler, Thiago Y. Oliveira, Michael J. Peluso, Joshua Tisdell Schiffer, Lillian B. Cohn, Steven G. Deeks, Michel C. Nussenzweig · 2023 · Nature Communications
68. Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Philip Arandjelovic, Youry Kim, James P. Cooney, Simon Preston, Marcel Doerflinger, James H. McMahon, Sarah E. Garner, Jennifer M. Zerbato, Michael Roche, Carolin Tumpach et al. · 2023 · Cell Reports Medicine
69. Immunomodulatory Activity of Tyrosine Kinase Inhibitors to Elicit Cytotoxicity Against Cancer and Viral Infection
    Núria Climent, Montserrat Plana · 2019 · Frontiers in Pharmacology
70. Factors that mold the nuclear landscape of HIV-1 integration
    Gregory J. Bedwell, Alan Engelman · 2020 · Nucleic Acids Research
71. Instability of 8E5 calibration standard revealed by digital PCR risks inaccurate quantification of HIV DNA in clinical samples by qPCR
    Eloise J. Busby, Alexandra S. Whale, Ruth Bridget Ferns, Paul R. Grant, Gary Morley, Jonathan Campbell, Carole A. Foy, Eleni Nastouli, Jim F. Huggett, Jeremy A. Garson · 2017 · Scientific Reports
72. HIV integration sites and implications for maintenance of the reservoir
    Jori Symons, Paul U. Cameron, Sharon R. Lewin · 2017 · Current Opinion in HIV and AIDS
73. Targeting Immune Checkpoint Molecules to Eliminate Latent HIV
    Zoe Boyer, Sarah Palmer · 2018 · Frontiers in Immunology
74. Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections
    Elizabeth M. Anderson, Francesco Roberto Simonetti, Robert J. Gorelick, Shawn Hill, Monica A. Gouzoulis, Jennifer Bell, Catherine A. Rehm, Liliana Pérez, Eli Boritz, Xiaolin Wu et al. · 2020 · Viruses
75. Long-term remission despite clonal expansion of replication-competent HIV-1 isolates
    Rebecca T. Veenhuis, Abena K. Kwaa, Caroline C. Garliss, Rachel Latanich, María Salgado, Christopher W. Pohlmeyer, Christopher L. Nobles, John Gregg, Eileen P. Scully, Justin R. Bailey et al. · 2018 · JCI Insight
76. Clonal expansion of SIV-infected cells in macaques on antiretroviral therapy is similar to that of HIV-infected cells in humans
    Andrea L. Ferris, David W. Wells, Shuang Guo, Gregory Q. Del Prete, Adrienne E. Swanstrom, John M. Coffin, Xiaolin Wu, Jeffrey D. Lifson, Stephen H. Hughes · 2019 · PLoS Pathogens
77. Analysis of unusual and signature APOBEC-mutations in HIV-1 pol next-generation sequences
    Philip L. Tzou, Sergei L. Kosakovsky Pond, Santiago Ávila‐Ríos · 2020 · PLoS ONE
78. Measuring the Size of the Latent Human Immunodeficiency Virus Reservoir: The Present and Future of Evaluating Eradication Strategies
    Timothy J. Henrich, Steven G. Deeks, Satish K. Pillai · 2017 · The Journal of Infectious Diseases
79. Despite early antiretroviral therapy effector memory and follicular helper CD4 T cells are major reservoirs in visceral lymphoid tissues of SIV-infected macaques
    Henintsoa Rabezanahary, Félicien Moukambi, David Palesch, Julien A. Clain, Gina Racine, Guadalupe Andreani, Ghita Benmadid-Laktout, Ouafa Zghidi‐Abouzid, Calayselvy Soundaramourty, Cecile L. Tremblay et al. · 2019 · Mucosal Immunology
80. Epigenetic crosstalk in chronic infection with HIV-1
    Ulrike C. Lange, Roxane Verdikt, Amina Aït-Ammar, Carine M. Van Lint · 2020 · Seminars in Immunopathology
81. Measuring integrated HIV DNA ex vivo and in vitro provides insights about how reservoirs are formed and maintained
    Marilia Rita Pinzone, Una O’Doherty · 2018 · Retrovirology
82. HIV persistence: silence or resistance?
    Alexander O. Pasternak, Ben Berkhout · 2023 · Current Opinion in Virology
83. Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials
    Daniel B. Reeves, Yunda Huang, Elizabeth R. Duke, Bryan T. Mayer, Erwing Fabian Cardozo Ojeda, Florencia A. T. Boshier, David A. Swan, Morgane Rolland, Merlin Lee Robb, John R. Mascola et al. · 2020 · PLoS Computational Biology
84. Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment
    Hadega Aamer, Jan McClure, Daisy L. Ko, Janine R. Maenza, Ann C. Collier, Robert W. Coombs, James I. Mullins, Lisa M. Frenkel · 2020 · PLoS Pathogens
85. HSF1 inhibition attenuates HIV-1 latency reversal mediated by several candidate LRAs In Vitro and Ex Vivo
    Andrew E. Timmons, Emily J. Fray, Mithra R. Kumar, Fengting Wu, Weiwei Dai, C. Korin Bullen, Peggy Kim, Carrie A. Hetzel, Chao Yang, Subul A. Beg et al. · 2020 · Proceedings of the National Academy of Sciences
86. Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies
    Aurélie Delannoy, Mikaël Poirier, Brendan Bell · 2019 · Viruses
87. The Mtb -HIV Syndemic Interaction: Why Treating M. tuberculosis Infection May Be Crucial for HIV-1 Eradication
    Robyn Waters, Mthawelanga Ndengane, Melissa-Rose Abrahams, Collin R. Diedrich, Robert John Wilkinson, Anna K. Coussens · 2020 · Future Virology
88. Clearance of HIV infection by selective elimination of host cells capable of producing HIV
    Min Li, Wei Liu, Tonya Bauch, Edward A. Graviss, Roberto C. Arduino, Jason T. Kimata, Min Chen, Jin Wang · 2020 · Nature Communications
89. HIV Persistence on Antiretroviral Therapy and Barriers to a Cure
    Julia Sung, David M. Margolis · 2018 · Advances in experimental medicine and biology
90. HIV-1 Transcription but Not Intact Provirus Levels are Associated With Systemic Inflammation
    Alex J. Olson, Carolyn Coote, Jennifer E Snyder-Cappione, Nina Lin, Manish Sagar · 2020 · The Journal of Infectious Diseases
91. Benefits of antiretroviral therapy initiation during acute HIV infection
    Jozefien De Clercq, Sofie Rutsaert, Marie‐Angélique De Scheerder, Chris Verhofstede, Steven F. J. Callens, Linos Vandekerckhove · 2020 · Acta Clinica Belgica
92. Regional Analysis of Intact and Defective HIV Proviruses in the Brain of Viremic and Virally Suppressed People with HIV
    Thomas A. Angelovich, Catherine R. Cochrane, Jingling Zhou, Carolin Tumpach, Sarah J. Byrnes, Janna Jamal Eddine, Emily Waring, Kathleen Busman‐Sahay, Claire Deléage, Trisha A. Jenkins et al. · 2023 · Annals of Neurology
93. Therapeutic Targeting of HIV Reservoirs: How to Give T Cells a New Direction
    Hongbing Yang, Zoë Wallace, Lucy Dorrell · 2018 · Frontiers in Immunology
94. Discovery of False Elite Controllers: HIV Antibody-Positive RNA-Negative Blood Donors Found To Be on Antiretroviral Therapy
    Wendy Sykes, Karin van den Berg, Genevieve Jacobs et al. · 2019 · The Journal of Infectious Diseases
95. STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques
    Takuya Yamamoto, Tomohiro Kanuma, Shokichi Takahama · 2019 · Scientific Reports
96. Predicting the broadly neutralizing antibody susceptibility of the HIV reservoir
    Wen‐Han Yu, David G. Su, Julia Torabi, Christine M. Fennessey, Andrea R. Shiakolas, Rebecca M. Lynch, Tae‐Wook Chun, Nicole A. Doria‐Rose, Galit Alter, Michael S. Seaman et al. · 2019 · JCI Insight
97. Sequential Vacc-4x and romidepsin during combination antiretroviral therapy (cART): Immune responses to Vacc-4x regions on p24 and changes in HIV reservoirs
    Gonzalo Tapia, Jesper Falkesgaard Højen, Mats Ökvist et al. · 2017 · Journal of Infection
98. Assays to Measure Latency, Reservoirs, and Reactivation
    Janet D'Angelo Siliciano, Robert F. Siliciano · 2017 · Current topics in microbiology and immunology
99. Evaluating the Intactness of Persistent Viral Genomes in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Initiating Antiretroviral Therapy within One Year of Infection
    Samuel Long, Christine M. Fennessey, Laura P. Newman, Carolyn Reid, Sean P. O’Brien, Yuan Li, Gregory Q. Del Prete, Jeffrey D. Lifson, Robert J. Gorelick, Brandon F. Keele · 2019 · Journal of Virology
100. HIV-1 Latency and Latency Reversal: Does Subtype Matter?
     Indra Sarabia, Alberto Bosque · 2019 · Viruses